KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) Asset Writedowns and Impairment (2017 - 2025)

Xylem filings provide 10 years of Asset Writedowns and Impairment readings, the most recent being $2.0 million for Q2 2025.

  • For the quarter ending Q2 2025, Asset Writedowns and Impairment fell 84.62% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Mar 2026, down 91.3%, and an annual FY2025 reading of $8.0 million, up 14.29% over the prior year.
  • Asset Writedowns and Impairment hit $2.0 million in Q2 2025 for Xylem, down from $4.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $14.0 million in Q3 2022, with the low at $1.0 million in Q1 2021.
  • Median Asset Writedowns and Impairment over the past 5 years was $1.5 million (2021), compared with a mean of $3.9 million.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 92.86% in 2023, then skyrocketed 500.0% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then soared by 500.0% to $6.0 million in 2024, then plummeted by 66.67% to $2.0 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $2.0 million, $4.0 million, and $6.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.